newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences to Hold Corporate Update on November 25th

AUSTIN, Texas, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for Alzheimer's disease, today announced it will